Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate

Background: Fluorescence confocal microscopy (FCM) is a novel micro-imaging technique providing optical sections of examined tissue. The method has been well established for the diagnosis of tumors in dermatological specimens. Methods: We compare intraoperative diagnoses of the real-time application...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ulf Titze, Torsten Hansen, Christoph Brochhausen, Barbara Titze, Birte Schulz, Alfons Gunnemann, Bernardo Rocco, Karl-Dietrich Sievert
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/78fcfef9fc2241e686c7f6b9a4cc9baa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:78fcfef9fc2241e686c7f6b9a4cc9baa
record_format dspace
spelling oai:doaj.org-article:78fcfef9fc2241e686c7f6b9a4cc9baa2021-11-25T17:02:38ZDiagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate10.3390/cancers132256852072-6694https://doaj.org/article/78fcfef9fc2241e686c7f6b9a4cc9baa2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5685https://doaj.org/toc/2072-6694Background: Fluorescence confocal microscopy (FCM) is a novel micro-imaging technique providing optical sections of examined tissue. The method has been well established for the diagnosis of tumors in dermatological specimens. Methods: We compare intraoperative diagnoses of the real-time application of FCM in pre-therapeutic prostate biopsies (35 patients, total number of biopsy specimens: n = 438) with the findings of conventional histology. Results: Prostate carcinoma was reliably diagnosed in all patients. Depending on scan quality and experience of the examiner, smaller lesions of well differentiated carcinoma (ISUP1) could not be consistently differentiated from reactive changes. Furthermore, in some cases there was difficulty to distinguish ISUP grade 2 from ISUP grade 1 tumors. ISUP grades 3–5 were reliably detected in FCM. Conclusions: Despite some limitations, FCM seems to be an effective tool for the timely assessment of prostate biopsies enabling reliable diagnosis of prostate cancer in patients requiring therapy.Ulf TitzeTorsten HansenChristoph BrochhausenBarbara TitzeBirte SchulzAlfons GunnemannBernardo RoccoKarl-Dietrich SievertMDPI AGarticleconfocal microscopyprostate cancerdigital pathologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5685, p 5685 (2021)
institution DOAJ
collection DOAJ
language EN
topic confocal microscopy
prostate cancer
digital pathology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle confocal microscopy
prostate cancer
digital pathology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ulf Titze
Torsten Hansen
Christoph Brochhausen
Barbara Titze
Birte Schulz
Alfons Gunnemann
Bernardo Rocco
Karl-Dietrich Sievert
Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate
description Background: Fluorescence confocal microscopy (FCM) is a novel micro-imaging technique providing optical sections of examined tissue. The method has been well established for the diagnosis of tumors in dermatological specimens. Methods: We compare intraoperative diagnoses of the real-time application of FCM in pre-therapeutic prostate biopsies (35 patients, total number of biopsy specimens: n = 438) with the findings of conventional histology. Results: Prostate carcinoma was reliably diagnosed in all patients. Depending on scan quality and experience of the examiner, smaller lesions of well differentiated carcinoma (ISUP1) could not be consistently differentiated from reactive changes. Furthermore, in some cases there was difficulty to distinguish ISUP grade 2 from ISUP grade 1 tumors. ISUP grades 3–5 were reliably detected in FCM. Conclusions: Despite some limitations, FCM seems to be an effective tool for the timely assessment of prostate biopsies enabling reliable diagnosis of prostate cancer in patients requiring therapy.
format article
author Ulf Titze
Torsten Hansen
Christoph Brochhausen
Barbara Titze
Birte Schulz
Alfons Gunnemann
Bernardo Rocco
Karl-Dietrich Sievert
author_facet Ulf Titze
Torsten Hansen
Christoph Brochhausen
Barbara Titze
Birte Schulz
Alfons Gunnemann
Bernardo Rocco
Karl-Dietrich Sievert
author_sort Ulf Titze
title Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate
title_short Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate
title_full Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate
title_fullStr Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate
title_full_unstemmed Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate
title_sort diagnostic performance of ex vivo fluorescence confocal microscopy in the assessment of diagnostic biopsies of the prostate
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/78fcfef9fc2241e686c7f6b9a4cc9baa
work_keys_str_mv AT ulftitze diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT torstenhansen diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT christophbrochhausen diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT barbaratitze diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT birteschulz diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT alfonsgunnemann diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT bernardorocco diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
AT karldietrichsievert diagnosticperformanceofexvivofluorescenceconfocalmicroscopyintheassessmentofdiagnosticbiopsiesoftheprostate
_version_ 1718412784201367552